comparison of bilastine with cetirizine or fexofenadine in chronic spontaneous urticaria
Not Applicable
- Conditions
- Health Condition 1: L501- Idiopathic urticaria
- Registration Number
- CTRI/2020/06/025959
- Lead Sponsor
- Department of Dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with chronic spontaneous urticaria , wheals and pruritis persiting for most of the days , for more than 6 weeks
2. patients more than 12 years of age.
Exclusion Criteria
1.Patients taking systemic steroid or immunosuppressive therapy in the last 2 weeks
2. Patients with severe life threatening illness 3. Pregnant and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method